Exelixis
EXEL
#1702
Rank
$12.60 B
Marketcap
$50.13
Share price
-1.90%
Change (1 day)
8.37%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company